Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib

Overview of attention for article published in BMC Cancer, April 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)
Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 54 Dimensions

Readers on

mendeley: 45 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

BLOOD CELL-FREE DNA-BASED METHOD FOR PREDICTING PROGNOSIS OF LIVER CANCER TREATMENT

Application WO-2020171573-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.